Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling

Bacillus Calmette-Guérin (BCG) is the first line treatment for bladder cancer and it is also proposed for melanoma immunotherapy. BCG modulates the tumor microenvironment (TME) inducing an antitumor effective response, but the immune mechanisms involved still poorly understood. The immune profile of...

Повний опис

Бібліографічні деталі

Автори:	Vinícius M. Borges, Fábio V. Marinho, Christiane V. A. Caldeira, Nina M. G. P. de Queiroz, Sergio C. Oliveira
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-05-01
Серія:	Frontiers in Immunology
Предмети:	Bacillus Calmette-Guérin (BCG) cancer immunotherapy melanoma innate immune pathways MyD88 TLRs
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1380069/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!